M. Jurado-rekin lankidetzan egindako argitalpenak (18)

2022

  1. Autophagy in Hematological Malignancies

    Cancers, Vol. 14, Núm. 20

  2. Type 2 Diabetes-Related Variants Influence the Risk of Developing Prostate Cancer: A Population-Based Case-Control Study and Meta-Analysis

    Cancers, Vol. 14, Núm. 10

  3. Validation and functional characterization of GWAS-identified variants for chronic lymphocytic leukemia: a CRuCIAL study

    Blood Cancer Journal

2021

  1. Polymorphisms within the TNFSF4 and mapkapk2 loci influence the risk of developing invasive aspergillosis: A two-stage case control study in the context of the aspbiomics consortium

    Journal of Fungi, Vol. 7, Núm. 1, pp. 1-17

  2. Validation of GWAS-Identified Variants for Anti-TNF Drug Response in Rheumatoid Arthritis: A Meta-Analysis of Two Large Cohorts

    Frontiers in Immunology, Vol. 12

2020

  1. Host immune genetic variations influence the risk of developing acute myeloid leukaemia: results from the NuCLEAR consortium

    Blood Cancer Journal, Vol. 10, Núm. 7

  2. NFKB2 polymorphisms associate with the risk of developing rheumatoid arthritis and response to TNF inhibitors: Results from the REPAIR consortium

    Scientific Reports, Vol. 10, Núm. 1

  3. Polymorphisms within the ARNT2 and CX3CR1 genes are associated with the risk of developing invasive aspergillosis

    Infection and Immunity, Vol. 88, Núm. 4

2019

  1. Steroid hormone-related polymorphisms associate with the development of bone erosions in rheumatoid arthritis and help to predict disease progression: Results from the REPAIR consortium

    Scientific Reports, Vol. 9, Núm. 1

  2. Tumor genetic alterations and features of the immune microenvironment drive myelodysplastic syndrome escape and progression

    Cancer Immunology, Immunotherapy, Vol. 68, Núm. 12, pp. 2015-2027

2018

  1. Genomic loss of HLA alleles may affect the clinical outcome in low-risk myelodysplastic syndrome patients

    Oncotarget, Vol. 9, Núm. 97, pp. 36929-36944

2017

  1. Adipose tissue-derived mesenchymal stromal cells as part of therapy for chronic graft-versus-host disease: A phase I/II study

    Cytotherapy, Vol. 19, Núm. 8, pp. 927-936

  2. Co-mutated CALR and MPL driver genes in a patient with myeloproliferative neoplasm

    Annals of Hematology

2016

  1. Early mortality in multiple myeloma: the time-dependent impact of comorbidity: A population-based study in 621 real-life patients

    American Journal of Hematology, Vol. 91, Núm. 7, pp. 700-704

  2. Polymorphisms in host immunity-modulating genes and risk of invasive aspergillosis: Results from the AspBIOmics Consortium

    Infection and Immunity, Vol. 84, Núm. 3, pp. 643-657

2015

  1. Trends in survival of multiple myeloma: A thirty-year population-based study in a single institution

    Cancer Epidemiology, Vol. 39, Núm. 5, pp. 693-699

2011

  1. Molecular and flow cytometry characterization during the follow-up of three simultaneous lymphoproliferative disorders: Hairy cell leukemia, monoclonal B-cell lymphocytosis, and CD4 ++/CD8 +/-dim T-large granular lymphocytosis - A case report

    Cytometry Part B - Clinical Cytometry, Vol. 80 B, Núm. 3, pp. 195-200

2002

  1. Expansion of cells with trisomy 12 associated with progressive lymphocytosis and a dramatic change in chimera status in a patient with chronic lymphocytic leukemia.

    Haematologica, Vol. 87, Núm. 7